Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Second Multicenter Hemophilia Cohort Study

NCT00341705 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00341705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00341705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Second Multicenter Hemophilia Cohort Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
April 27, 2001
Completion date
April 2, 2013
Enrollment
2,565 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver decompensation, non-hodgkin lymphoma